Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$16.95 - $27.04 $1.24 Million - $1.98 Million
73,300 New
73,300 $1.98 Million
Q3 2023

Nov 08, 2023

BUY
$14.99 - $32.65 $20,986 - $45,710
1,400 Added 1.67%
85,200 $1.28 Million
Q2 2023

Aug 09, 2023

BUY
$29.76 - $46.14 $44,640 - $69,210
1,500 Added 1.82%
83,800 $2.72 Million
Q1 2023

May 10, 2023

SELL
$38.09 - $57.79 $106,652 - $161,812
-2,800 Reduced 3.29%
82,300 $3.22 Million
Q4 2022

Feb 08, 2023

BUY
$40.54 - $56.2 $72,972 - $101,160
1,800 Added 2.16%
85,100 $4.5 Million
Q3 2022

Nov 09, 2022

BUY
$36.98 - $49.2 $40,678 - $54,120
1,100 Added 1.34%
83,300 $3.75 Million
Q2 2022

Aug 09, 2022

BUY
$28.03 - $45.8 $106,514 - $174,040
3,800 Added 4.85%
82,200 $2.99 Million
Q1 2022

May 09, 2022

BUY
$29.24 - $44.06 $175,440 - $264,360
6,000 Added 8.29%
78,400 $3.24 Million
Q3 2021

Nov 08, 2021

BUY
$44.0 - $65.8 $57,200 - $85,540
1,300 Added 1.83%
72,400 $3.98 Million
Q2 2021

Aug 06, 2021

BUY
$44.66 - $63.06 $401,939 - $567,540
9,000 Added 14.49%
71,100 $3.4 Million
Q1 2021

May 07, 2021

BUY
$46.31 - $62.7 $55,572 - $75,240
1,200 Added 1.97%
62,100 $3.15 Million
Q4 2020

Feb 05, 2021

BUY
$55.51 - $69.94 $16,653 - $20,982
300 Added 0.5%
60,900 $3.84 Million
Q3 2020

Nov 09, 2020

BUY
$42.19 - $69.61 $46,409 - $76,571
1,100 Added 1.85%
60,600 $4.07 Million
Q2 2020

Aug 05, 2020

BUY
$27.55 - $43.28 $650,180 - $1.02 Million
23,600 Added 65.74%
59,500 $2.49 Million
Q1 2020

May 08, 2020

BUY
$23.16 - $47.8 $16,212 - $33,460
700 Added 1.99%
35,900 $1.13 Million
Q4 2019

Feb 06, 2020

BUY
$27.97 - $40.38 $984,544 - $1.42 Million
35,200 New
35,200 $1.42 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.